Caris Life Sciences, Inc. CAI
18.54 USD -0.96 (-4.92%)
Regular-session close
18.54 0.00 0.00%
After hours · Nov 19, 4:26 PM ET
18.52 Day range 20.82
14.19 52-week range 36.50
- YTD
- -31.28%
- 1 year
- -22.43%
News
businesswire.com CAI Enters Into a Definitive Agreement with PQE Group, Expanding Global Life Sciences Reach INDIANAPOLIS--(BUSINESS WIRE)--CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments, has entered into a…benzinga.com Piper Sandler Maintains Neutral on Caris Life Sciences, Raises Price Target to $25 Piper Sandler analyst David Westenberg maintains Caris Life Sciences (NASDAQ:CAI) with a Neutral and raises the price target from $22 to $25.
benzinga.com Citigroup Maintains Buy on Caris Life Sciences, Raises Price Target to $36 Citigroup analyst Albert Hu maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $28 to $36.
benzinga.com TD Cowen Maintains Buy on Caris Life Sciences, Raises Price Target to $38 TD Cowen analyst Dan Brennan maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $36 to $38.
benzinga.com VIX Spikes 39% as AI Tech Rout Wipes Out $2.2 Trillion: Stock Market Today The AI sell-off deepens after the Democratic midterm sweep, sending the S&P 500 toward its worst day since April 2025 as Nvidia, AMD and Micron sank.
benzinga.com Zillow Posts Downbeat Q3 Results, Joins HubSpot, Snap And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session U.S. stock futures were mixed as Zillow and several companies fell sharply premarket after weak results and lowered sales guidance.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers ADMA Biologics (NASDAQ:ADMA) shares rose 19.6% to $12.53 during Thursday's pre-market session. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3…
benzinga.com Caris Life Sciences Q3 2026 Earnings Call Transcript Caris Life Sciences (NASDAQ:CAI) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…benzinga.com Caris Life Sciences Raises FY2026 Sales Guidance from $1.030B-$1.040B to $1.040B-$1.050B vs $1.030B Est Caris Life Sciences (NASDAQ:CAI) raises FY2026 sales outlook from $1.030 billion-$1.040 billion to $1.040 billion-$1.050 billion vs $1.030 billion estimate.
benzinga.com Caris Life Sciences Q3 EPS $0.05 Beats $0.04 Estimate, Sales $275.358M Beat $255.363M Estimate Caris Life Sciences (NASDAQ:CAI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 37.5 percent decrease over earnings of…
benzinga.com BTIG Maintains Buy on Caris Life Sciences, Raises Price Target to $38 BTIG analyst Mark Massaro maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $33 to $38.
benzinga.com Canaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30 Canaccord Genuity analyst Kyle Mikson maintains Caris Life Sciences (NASDAQ:CAI) with a Hold and raises the price target from $22 to $30.
